000			02211 a2200577 4500
005			20250518032101.0
264		0	_c20200813
008			202008s 0 0 eng d
022			_a2013-2514
024	7		_a10.1016/j.nefro.2018.10.016 _2doi
040			_aNLM _beng _cNLM
100	1		_ade Francisco, Angel L M
245	0	0	_aOnco-Nephrology: Cancer, chemotherapy and kidney. _h[electronic resource]
260			_bNefrologia _c
300			_a473-481 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAcrylonitrile _xadverse effects
650	0	4	_aAcute Kidney Injury _xchemically induced
650	0	4	_aAngiogenesis Inhibitors _xadverse effects
650	0	4	_aAniline Compounds _xadverse effects
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aBiomarkers _xblood
650	0	4	_aContrast Media _xadverse effects
650	0	4	_aCreatinine _xblood
650	0	4	_aCyclins _xantagonists & inhibitors
650	0	4	_aErbB Receptors _xantagonists & inhibitors
650	0	4	_aGlomerular Filtration Rate _xdrug effects
650	0	4	_aHumans
650	0	4	_aImmunotherapy, Adoptive _xmethods
650	0	4	_aKidney _xdrug effects
650	0	4	_aKidney Neoplasms _xcomplications
650	0	4	_aMolecular Targeted Therapy _xadverse effects
650	0	4	_aNeoplasms _xcomplications
650	0	4	_aNephrectomy _xadverse effects
650	0	4	_aPoly(ADP-ribose) Polymerase Inhibitors _xtherapeutic use
650	0	4	_aPostoperative Complications _xetiology
650	0	4	_aProto-Oncogene Proteins B-raf _xantagonists & inhibitors
650	0	4	_aReferral and Consultation _xstatistics & numerical data
650	0	4	_aRenal Dialysis _xadverse effects
650	0	4	_aRenal Insufficiency, Chronic _xcomplications
650	0	4	_aTOR Serine-Threonine Kinases _xantagonists & inhibitors
700	1		_aMacía, Manuel
700	1		_aAlonso, Fabiola
700	1		_aGarcía, Patricia
700	1		_aGutierrez, Eduardo
700	1		_aQuintana, Luis Fernando
700	1		_aQuiroga, Borja
700	1		_aTorregrosa, Isidro
773	0		_tNefrologia _gvol. 39 _gno. 5 _gp. 473-481
856	4	0	_uhttps://doi.org/10.1016/j.nefro.2018.10.016 _zAvailable from publisher's website
999			_c29534770 _d29534770